fda warning letter compounding semaglutide news Last month, the issued 25 letters to telehealth companies over what it called false or misleading claims about compounded GLP-1 medications FDA ramps up its pushback

Post-marketing surveillance of approved drugs involves millions of users over years, and often reveals rare side effects that clinical trials miss

While all states cover at least one Type 2 diabetes-indicated GLP-1, coverage for obesity-indicated options is less consistent

GLP-1 stands for glucagon-like peptide-1, which is a hormone your body naturally produces to regulate appetite and blood sugar

Anxiety vitamin D is so closely linked that some experts recommend having its levels checked for any anxiety condition

Recent findings show those on the highest dose of retatrutide lost an average of 28.7% of their body weight over 68 weeks